A Drug That Prevents Organ Transplant Rejection in Humans May Also Extend Canine Longevity
Continued on page 128
Dr. Matt Kaeberlein pictured with his Keeshond and German Shepherd Dog. Although his current research project involving dogs will help develop rapamycin as an ageing preventative for humans, he views that as a parallel goal. As a lifetime dog lover, he believes there is intrinsic value in improving the quality of dogs’ lives in their later years and extending their lifespan. “The studies would be warranted on that basis alone,” he says. Photo by Dr. Tammi Kaeberlein.
Research is underway to determine if rapamycin would extend canine lifespan by slowing the progression of diseases associated with the aging process. 40 Dog News